Dr. Glenn J. Hanna, MD
Claim this profileDana Farber Cancer Institute
Expert in Skin Cancer
Studies Cancer
20 reported clinical trials
38 drugs studied
Area of expertise
1Skin Cancer
Global LeaderStage IV
HPV positive
HPV negative
2Cancer
Stage IV
HPV positive
HPV negative
Affiliated Hospitals
Clinical Trials Glenn J. Hanna, MD is currently running
T-DM1 + Chemoradiation
for Salivary Gland Cancer
This trial is testing a special drug called T-DM1 combined with regular cancer treatments in patients with HER2-positive salivary gland cancer. The drug targets cancer cells specifically and delivers chemotherapy directly to them. The goal is to see if this combination is safe and effective in preventing cancer recurrence. T-DM1 has shown effectiveness in treating HER2-positive cancers, including breast and salivary gland cancers, by targeting cancer cells and delivering chemotherapy directly to them.
Recruiting1 award Phase 221 criteria
ZM008 Alone and With Pembrolizumab
for Cancer
This is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Pembrolizumab in patients with advanced solid tumors who have exhausted all standard therapy available or are intolerant of the same.
Recruiting1 award Phase 17 criteria
More about Glenn J. Hanna, MD
Clinical Trial Related4 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Glenn J. Hanna, MD has experience with
- Nivolumab
- Cetuximab
- Ipilimumab
- RP2
- CB-103
- Lenvatinib
Breakdown of trials Glenn J. Hanna, MD has run
Skin Cancer
Cancer
Squamous Cell Carcinoma
Adenoid Cystic Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Glenn J. Hanna, MD specialize in?
Glenn J. Hanna, MD focuses on Skin Cancer and Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are HPV positive.
Is Glenn J. Hanna, MD currently recruiting for clinical trials?
Yes, Glenn J. Hanna, MD is currently recruiting for 10 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Glenn J. Hanna, MD has studied deeply?
Yes, Glenn J. Hanna, MD has studied treatments such as Nivolumab, Cetuximab, Ipilimumab.
What is the best way to schedule an appointment with Glenn J. Hanna, MD?
Apply for one of the trials that Glenn J. Hanna, MD is conducting.
What is the office address of Glenn J. Hanna, MD?
The office of Glenn J. Hanna, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.